# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Nikola Tesla (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI009-SYN-TD
- Date: 1902-02-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Branimir Kovač-Holt, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six-week OCD treatment review. **S**

## History of present illness

Mr. Tesla returns six weeks after starting sertraline 50 mg. He has had no side effects since the first week and has missed no doses. He has had five ERP sessions and has practiced touching door handles without washing for ten minutes, and eating lunch without calculating its volume on two days a week. He washes about 30 times a day. Counting his steps is still hard to resist, and repeating laboratory steps in threes still costs him about two hours a day. He saw the dietitian and now eats three meals on most days. He sleeps about five hours. He has had no suicidal thoughts. **S**

| Element | Detail |
|---|---|
| Interval change | Washing down to about 30 times a day; two meals a week without calculating |
| Psychotherapy | Five ERP sessions with homework |
| Rituals | About two hours a day of counting and repeating |
| Nutrition | Dietitian seen; three meals most days |
| Safety | No suicidal thoughts |
| Y-BOCS | 24, down from 28 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Negative | No nausea or diarrhea |
| Integumentary | Positive | Hands still dry; no open cracks |
| Psychiatric | Positive | Counting and repeating persist; mood a little better; no suicidal thoughts |

3 systems reviewed. **S**

## Current medications

- Sertraline 100 mg oral tablet, one tablet by mouth each morning **S**
- White petrolatum ointment, apply to both hands after each wash and at bedtime **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/72 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 99% on room air; weight 64.6 kg; BMI 18.3 kg/m². All vital signs are synthetic.

PHQ-9: 6; GAD-7: 10. All results are synthetic.

## Change since baseline

- PHQ-9: 8 at baseline, 6 at this visit **S**
- GAD-7: 12 at baseline, 10 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Thin; more relaxed |
| Skin | Examined with his agreement after he sanitized his hands: dry skin over both hands with no fissures |
| Mental status | Precise and engaged; mood "slightly lighter"; affect anxious but reactive; good insight; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Obsessive-compulsive disorder, early improvement** (F42.2). Y-BOCS 24, down 14 percent from 28: early improvement, well short of a response, which in OCD often takes eight to twelve weeks or more. PHQ-9 6 and GAD-7 10. Suicide risk remains low. **S**
   - Increase sertraline to 100 mg each morning; nurse telephone check in two weeks for side effects.
   - Continue weekly ERP, adding counting and repeating targets.
   - Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.
2. **Underweight from food rituals** (R63.6). Up 0.8 kg since intake to 64.6 kg. **S**
   - Three meals a day; one meal a day without calculating as an exposure task.
3. **Insufficient sleep** (Z72.820). About five hours a night. **S**
   - Keep the sleep diary; no laboratory work after midnight.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Y-BOCS severity score (recorded in the note; no LOINC code found) | At baseline and about every 4 to 6 weeks during acute treatment | Completed today | 24, down 14 percent from 28; dose increased |
| Survey | PHQ-9 and GAD-7 for secondary depression and anxiety | At baseline and periodically while depressive or anxiety symptoms are present | Completed today | PHQ-9 6 (item 9 scored 0); GAD-7 10 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given) | Every visit during acute treatment | Completed today | No suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Medication safety | Sertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects) | Every visit and two weeks after each dose increase | Completed today | No side effects since week one; no missed doses; dose increased to 100 mg, with a nurse call in two weeks |
| Self-management | Exposure and response prevention attendance and homework | Every visit during acute treatment | Completed today | Five sessions; door handles without washing for ten minutes; two meals a week without calculating |
| Examination | Weight and BMI | Every visit while underweight | Completed today | 64.6 kg, BMI 18.3, up 0.8 kg |
| Examination | Hand skin | Every visit while dermatitis is present | Completed today | Dry; no fissures |
| Self-management | Sleep diary | Every visit during acute treatment | Completed today | About five hours a night |
| Medication safety | Antipsychotic augmentation monitoring (weight, glucose, lipids, movement) | Only if an antipsychotic is added | Not indicated | No augmentation; responding to sertraline and ERP |

## Goal progress

- Y-BOCS down by at least 35 percent (treatment response) by twenty-four weeks. In progress; target 1902-06-30. **S**
- Rituals under one hour a day, with meals eaten without calculating. In progress; target 1902-06-30. **S**
- BMI at least 18.5 with three meals a day. In progress; target 1902-06-30. **S**
- Hands healed, with washing under 15 times a day. In progress; target 1902-04-07. **S**
- At least six hours of sleep most nights. In progress; target 1902-06-30. **S**

## Medication changes

- Stopped: Sertraline 50 mg oral tablet, one tablet by mouth each morning **S**
- Started: Sertraline 100 mg oral tablet, one tablet by mouth each morning **S**

## Guideline basis

- Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007), American Psychiatric Association
- Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013), American Psychiatric Association
- Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005), National Institute for Health and Care Excellence
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Review in six weeks. **S**
- Next scheduled visit 1902-04-07: twelve-week OCD treatment review. **S**
